Terumo Corp. (OTCMKTS:TRUMY) Sees Significant Drop in Short Interest

Terumo Corp. (OTCMKTS:TRUMY) was the target of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 46,134 shares, a decrease of 46.0% from the July 15th total of 85,412 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 251,156 shares, the short-interest ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy”.

Terumo Stock Down 3.0%

OTCMKTS:TRUMY opened at $15.94 on Wednesday. The company has a market cap of $23.51 billion, a price-to-earnings ratio of 22.45 and a beta of 0.68. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.97 and a current ratio of 1.59. The stock’s fifty day moving average price is $14.29 and its two-hundred day moving average price is $13.69. Terumo has a 52-week low of $12.08 and a 52-week high of $19.60.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, August 7th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.17 by $0.13. The company had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Terumo had a return on equity of 10.55% and a net margin of 13.83%. On average, analysts anticipate that Terumo will post 0.7 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.